Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 6/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 4/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12402093 | 0.81 | MEN1 (0.47) | LMNAMEN1KMT2APABPC1ATM | |
| SCHEMBL496910 | 0.70 | ELANE (0.60) | LMNAELANEMEN1KMT2APABPC1 | |
| SCHEMBL2905863 | 0.68 | HKDC1 (0.47) | MEN1KMT2APABPC1ATMERAP1 | |
| SCHEMBL2163644 | 0.67 | MEN1 (0.60) | MEN1KMT2APOLBGAAGFER | |
| SCHEMBL15417549 | 0.66 | HTR6 (0.62) | LMNAMEN1KMT2APOLBGAA | |
| SCHEMBL2167073 | 0.65 | MAPT (0.49) | ELANEMEN1KMT2AGAAALDH1A1 | |
| SCHEMBL29378861 | 0.65 | RAPGEF4 (0.46) | LMNAMEN1KMT2AERAP1POLB | |
| SCHEMBL7547398 | 0.65 | HTR6 (0.50) | LMNAMEN1KMT2APOLBGAA | |
| SCHEMBL28245930 | 0.65 | POLB (0.53) | MEN1KMT2APABPC1ATMERAP1 | |
| SCHEMBL7858524 | 0.64 | POLB (0.53) | MEN1KMT2APABPC1ATMERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8277695-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-10-02 | — | — | US | disclosed |
| EP-2032657-B1 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | BASF SE (DE) | 2011-08-10 | — | — | EP | disclosed |
| US-20110180767-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2011-07-28 | — | — | US | disclosed |
| EP-2032657-A2 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | Ciba Holding Inc. (CH) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007147847-A2 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | CIBA HOLDING INC. (CH) | 2007-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110180767-A1 | Reversibly thermochromic compositions | C1R, C3AR1, C9 | LMNA 2222/4885ELANE 4215/4885MEN1 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.